[
    "Step 1: Review the question and understand what it is asking. The question is asking which statement about insulin Afrezza is not true. Step 2: Review the documents for information about insulin Afrezza. Document [6] provides information about Afrezza. Step 3: Compare the information in the documents to the answer choices. A. Inhalational preparation of insulin - Document [6] confirms that Afrezza is a noninjectable insulin delivery option, which means it is inhaled. B. Not a substitute of injectable insulin - Document [6] states that Afrezza may offer an alternative for insulin na\u00efve patients who are hesitant about initiating traditional insulin, which suggests it can be a substitute for injectable insulin. C. Needs to be given in multiple doses - Document [6] does not provide specific information about the dosing of Afrezza, but it is generally true that insulin needs to be given in multiple doses. D. Used in combination with short acting insulin - Document [6] states that Afrezza is limited in type 1 diabetes to use in combination with basal insulin, not short acting insulin. Based on this analysis, the statement that is not true about insulin Afrezza is D. Used in combination with short acting insulin. Output: {\"step_by_step_thinking\": \"The question is asking which statement about insulin Afrezza is not true. Document [6] provides information about Afrezza. Based on this document, Afrezza is an inhalational preparation of insulin, can be a substitute for injectable insulin, and is used in combination with basal insulin, not short acting insulin. Therefore, the statement that is not true about insulin Afrezza is D. Used in combination with short acting insulin.\", \"answer_choice\": \"D\"}"
]